APA ציטוט

Kim, T., Havighurst, T., Kim, K., Albertini, M., Xu, Y. G., & Spiegelman, V. S. (2018). Targeting insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAF(V600E) inhibitors. Mol Carcinog.

Citação norma Chicago

Kim, TaeWon, Thomas Havighurst, KyungMann Kim, Mark Albertini, Yaohui G. Xu, and Vladimir S. Spiegelman. "Targeting Insulin-like Growth Factor 2 MRNA-binding Protein 1 (IGF2BP1) in Metastatic Melanoma to Increase Efficacy of BRAF(V600E) Inhibitors." Mol Carcinog 2018.

ציטוט MLA

Kim, TaeWon, et al. "Targeting Insulin-like Growth Factor 2 MRNA-binding Protein 1 (IGF2BP1) in Metastatic Melanoma to Increase Efficacy of BRAF(V600E) Inhibitors." Mol Carcinog 2018.